KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Change in Cash: 2009-2024

Historic Change in Cash for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to $239.0 million.

  • Bausch Health Companies' Change in Cash fell 417.32% to -$403.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $590.0 million, marking a year-over-year increase of 2066.67%. This contributed to the annual value of $239.0 million for FY2024, which is 35.58% down from last year.
  • Latest data reveals that Bausch Health Companies reported Change in Cash of $239.0 million as of FY2024, which was down 35.58% from $371.0 million recorded in FY2023.
  • In the past 5 years, Bausch Health Companies' Change in Cash ranged from a high of $371.0 million in FY2023 and a low of -$1.5 billion during FY2022.
  • Over the past 3 years, Bausch Health Companies' median Change in Cash value was $239.0 million (recorded in 2024), while the average stood at -$306.0 million.
  • In the last 5 years, Bausch Health Companies' Change in Cash tumbled by 604.29% in 2022 and then spiked by 124.28% in 2023.
  • Bausch Health Companies' Change in Cash (Yearly) stood at -$1.4 billion in 2020, then skyrocketed by 121.22% to $303.0 million in 2021, then tumbled by 604.29% to -$1.5 billion in 2022, then spiked by 124.28% to $371.0 million in 2023, then crashed by 35.58% to $239.0 million in 2024.